The structure and function of the molecules that carry human red blood cell and platelet antigens

被引:51
作者
Denomme, GA
机构
[1] Canadian Blood Serv, Toronto, ON M5G 2M1, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1016/j.tmrv.2004.03.006
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
A number of molecules on the surface of red blood cells (RBCs) and platelets express antigenic activity. Various biochemical and molecular approaches have been used to determine the structure and possible function that these molecules have for their respective cell types. The existence of variant molecules and null phenotypes and the immunological response to these antigens have aided in the analysis of the structure and function relationships of these molecules. A comparison of the sequence to moieties of known function and the presence of functional domains for many of the molecules allows for a prediction of their function. The proposed function of the molecules that express RBC and platelet antigens includes membrane structure, transporter or channel formation, receptor/ligand signaling or adhesion, enzyme activity, and glycocalyx formation. However, the function of some of these molecules is not known, and many of the variant antigens do not show an obvious functional difference. For unknown reasons, some of these molecules are exceptionally polymorphic and the elucidation of the precise role that these polymorphisms play in structure and function is hindered by limitations in the in vitro and ex vivo analyses and access to precursor cell types. The objective of this review is to define the structure and function of those molecules that express RBC and platelet antigens and the significance, if any, that polymorphisms have for these molecules. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:203 / 231
页数:29
相关论文
共 291 条
[1]
Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease [J].
Abboud, MR ;
Taylor, EC ;
Habib, D ;
Dantzler-Johnson, T ;
Jackson, SM ;
Xu, FS ;
Laver, J ;
Ballas, SK .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (02) :482-490
[2]
Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex [J].
Afshar-Kharghan, V ;
Li, CQ ;
Khoshnevis-Asl, M ;
López, JA .
BLOOD, 1999, 94 (01) :186-191
[3]
AFSHARKHARGHAN V, 2003, BLOOD
[4]
AGRE P, 1993, AM J PHYSIOL, V265, pF463
[5]
STRUCTURE AND FUNCTION OF THE COMPLEMENT RECEPTORS, CR-1 (CD35) AND CR-2 (CD21) [J].
AHEARN, JM ;
FEARON, DT .
ADVANCES IN IMMUNOLOGY, 1989, 46 :183-219
[6]
EVIDENCE THAT RED-BLOOD-CELL PROTEIN-P55 MAY PARTICIPATE IN THE SKELETON-MEMBRANE LINKAGE THAT INVOLVES PROTEIN-4.1 AND GLYCOPHORIN-C [J].
ALLOISIO, N ;
VENEZIA, ND ;
RANA, A ;
ANDRABI, K ;
TEXIER, P ;
GILSANZ, F ;
CARTRON, JP ;
DELAUNAY, J ;
CHISHTI, AH .
BLOOD, 1993, 82 (04) :1323-1327
[7]
NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS [J].
AMARA, SG ;
KUHAR, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :73-93
[8]
Characterization of the human leukocyte GPI-anchored glycoprotein CDw108 and its relation to other similar molecules [J].
Angelisová, P ;
Drbal, K ;
Cerny, J ;
Hilgert, I ;
Horejsí, V .
IMMUNOBIOLOGY, 1999, 200 (02) :234-245
[9]
ORIGIN OF THE 4TH COMPONENT OF COMPLEMENT RELATED CHIDO AND RODGERS BLOOD-GROUP ANTIGENS [J].
ATKINSON, JP ;
CHAN, AC ;
KARP, DR ;
KILLION, CC ;
BROWN, R ;
SPINELLA, D ;
SHREFFLER, DC ;
LEVINE, RP .
COMPLEMENT, 1988, 5 (02) :65-76
[10]
The Rh blood group system: a review [J].
Avent, ND ;
Reid, ME .
BLOOD, 2000, 95 (02) :375-387